The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction‐associated steatotic liver disease and metabolic dysfunction and alcohol‐associated liver disease
Although both metabolic steatotic liver disease and metabolic alcohol-associated liver disease were correlated with liver fibrosis progression in both sexes, the impact of alcohol consumption and cardiometabolic factors on fibrosis progression differed by sex. Cardiometabolic factors may have a stronger impact on liver fibrosis than alcohol consumption in males with metabolic dysfunction-associated steatotic liver disease.
Authors
- Yasuyuki Okada (ORCID: https://orcid.org/0000-0002-1867-8800)
- Takanori Miyake (ORCID: https://orcid.org/0000-0001-5650-8282)
- Masahiro Sogabe (ORCID: https://orcid.org/0000-0002-8214-1354)
- Yasushi Sato (ORCID: https://orcid.org/0000-0002-6776-4609)
- Tetsuji Takayama (ORCID: https://orcid.org/0000-0002-0175-1573)
- Tetsu Tomonari
- Yoshifumi Kida (ORCID: https://orcid.org/0000-0001-9202-1121)
- Yutaka Kawano (ORCID: https://orcid.org/0000-0002-2256-0776)
- Kaizo Kagemoto (ORCID: https://orcid.org/0000-0003-3524-2053)
- Reiko Yokoyama
- Toshiya Okahisa (ORCID: https://orcid.org/0000-0002-5444-995X)
- Tomoyuki Kawaguchi
- Ryo Shinomiya
- Masahiko Nakasono (ORCID: https://orcid.org/0000-0002-9672-1317)
- Takanori Kashihara
- Miwako Kagawa
Institutions
- Shikoku Central Hospital of the Mutual Aid Association of Public School Teachers (JP)
- Tokushima Municipal Hospital (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1111/apt.18280
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55